Log in

CVE:EMHEmerald Health Therapeutics Stock Price, Forecast & News

C$0.22
+0.01 (+4.88 %)
(As of 05/22/2020 04:00 PM ET)
Add
Compare
Today's Range
C$0.20
Now: C$0.22
C$0.23
50-Day Range
C$0.14
MA: C$0.17
C$0.26
52-Week Range
C$0.12
Now: C$0.22
C$3.85
Volume2.56 million shs
Average Volume691,833 shs
Market CapitalizationC$39.21 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis in Canada. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Victoria, Canada.
Read More
Emerald Health Therapeutics logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.05 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-250-8189838

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$17.02 million
Cash FlowC$0.04 per share
Book ValueC$1.26 per share

Profitability

Miscellaneous

Employees113
Market CapC$39.21 million
Next Earnings Date6/4/2020 (Estimated)
OptionableNot Optionable

Receive EMH News and Ratings via Email

Sign-up to receive the latest news and ratings for EMH and its competitors with MarketBeat's FREE daily newsletter.

Emerald Health Therapeutics (CVE:EMH) Frequently Asked Questions

How has Emerald Health Therapeutics' stock been impacted by COVID-19 (Coronavirus)?

Emerald Health Therapeutics' stock was trading at C$0.18 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, EMH shares have increased by 19.4% and is now trading at C$0.22. View which stocks have been most impacted by Coronavirus.

When is Emerald Health Therapeutics' next earnings date?

Emerald Health Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, June 4th 2020. View our earnings forecast for Emerald Health Therapeutics.

What price target have analysts set for EMH?

0 Wall Street analysts have issued twelve-month price objectives for Emerald Health Therapeutics' stock. Their forecasts range from C$1.50 to C$1.50. On average, they anticipate Emerald Health Therapeutics' share price to reach C$1.50 in the next twelve months. This suggests a possible upside of 597.7% from the stock's current price. View analysts' price targets for Emerald Health Therapeutics.

Has Emerald Health Therapeutics been receiving favorable news coverage?

Media headlines about EMH stock have been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Emerald Health Therapeutics earned a news sentiment score of -1.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View the latest news aboutEmerald Health Therapeutics.

Who are some of Emerald Health Therapeutics' key competitors?

What other stocks do shareholders of Emerald Health Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Emerald Health Therapeutics investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Alibaba Group (BABA), Micron Technology (MU), Charlotte's Web (CWBHF), OrganiGram (OGI), Canopy Growth (CGC), Emerald Health Therapeutics (EMHTF) and Crispr Therapeutics (CRSP).

Who are Emerald Health Therapeutics' key executives?

Emerald Health Therapeutics' management team includes the following people:
  • Dr. Avtar S. Dhillon, Exec. Chairman, Pres & Principal Exec. Officer (Age 57)
  • Mr. Robert C. Hill C.P.A., CPA, CA, CFO & Corp. Sec.
  • Mr. Christopher W. Wagner, Consultant (Age 50)
  • Mr. Michael Bierman, VP of Operations
  • Mr. Allan Rewak, VP of Communications & Stakeholder Relations

What is Emerald Health Therapeutics' stock symbol?

Emerald Health Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EMH."

How do I buy shares of Emerald Health Therapeutics?

Shares of EMH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Emerald Health Therapeutics' stock price today?

One share of EMH stock can currently be purchased for approximately C$0.22.

How big of a company is Emerald Health Therapeutics?

Emerald Health Therapeutics has a market capitalization of C$39.21 million and generates C$17.02 million in revenue each year. Emerald Health Therapeutics employs 113 workers across the globe.

What is Emerald Health Therapeutics' official website?

The official website for Emerald Health Therapeutics is www.emerald.care.

How can I contact Emerald Health Therapeutics?

Emerald Health Therapeutics' mailing address is 4420 West Saanich Road, Rpo Royal Oak PO Box 24076, VICTORIA, BC V8Z 7E7, Canada. The company can be reached via phone at +1-250-8189838.

This page was last updated on 5/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.